Therapeutic Antibodies – Multimedia
Video
Safety Considerations for the Development of Antibody Drug Conjugates
Both the antibody and small molecule of an ADC can contribute to drug interactions, so they should be considered from a safety perspective. However, regulatory guidance is not well established. Here’s what you need to know.
Infographic
Tailored Purification Tools for Different Antibody Modalities
This infographic explores affinity resins specifically designed for the purification of different types of antibody modalities.
Infographic
Biopharma Analysis
Download this infographic to explore why it is important to analyze biopharmaceuticals and some of the methods commonly used.
eBook
Accelerating Antibody Discovery With Advanced Label-Free Technology
The development of antibodies for diagnostics or therapeutics requires comprehensive characterization of affinity, specificity and mechanism of action. In particular, antibody-drug conjugates (ADCs) are an exciting and emerging class of biopharmaceuticals with applications in cancer.
Poster
Accelerating Antibody Discovery Using BLI Biosensor Technology
Biolayer Interferometry (BLI) technology has greatly advanced the process of antibody discovery, and the latest platforms offer reliable, high precision analysis which researchers can rely on.
Poster
Accelerating Antibody Drug Development With Subdomain-Specific Affinity Chromatography
Affinity purification platforms such as Protein A or L are well-established in the manufacturing process of therapeutic monoclonal antibodies. However, with the development of engineered modalities such as bi-specific antibodies, fragments and Fc-fusion proteins, challenges in the downstream process of these molecules arise.
eBook
Purification Solutions for Therapeutic Antibodies
In recent years, different therapeutic antibody modalities have been developed to address different therapeutic needs.
Podcast
Unlocking the Power of Therapeutic Antibodies
In this episode of Opinionated Science we dive into the world of therapeutic antibodies with Bio-Rad.
Infographic
Facilitating Bispecific Antibody Drug Development Through Quality Control
This is especially critical for bispecific antibodies, which are regarded as the second generation of antibody cancer therapies.
Video
Single-Cell Isolation: When Art Is Not Enough With Andris Abramenkovs
In this episode, we speak with Andris Abramenkovs, product manager of CellCelector technology at Sartorius.
Advertisement